Hospital acquired infections (HAI), also known as nosocomial infections, describe infections that have been acquired during hospitalization or during treatment within a hospital or other clinical settings.

Common types of HAI are diarrhea, urinary-tract infections, sepsis caused by vein catheters, pneumonia and infections following surgery. 

All types of microorganisms, including bacteria and fungi, are known to cause HAI which are also difficult to treat, especially in case of antibiotic-resistant strains. Antimicrobial Resistance (AMR) are on the rise. Around 4.95 million deaths worldwide are associated with AMR (as of 2019). 

Culture is the gold standard for drug resistance testing. The time factor is particulary important for high risk patients. Therefore, a rapid supportive diagnostics e.g. PCR is important for initiating provisional therapy. In addition, PCR allows a fast and effective screening option for infections within a clinical setting. 

R-Biopharm offers different solutions for diagnostics of hospital aquired infections and drug resistance. 

You might also be interested in

RIDA®UNITY Norovirus I &...
For in vitro diagnostic use. The RIDA®UNITY Norovirus I & II test, performed on the RIDA®UNITY platform, is a multiplex real-time RT-PCR for th...
ridaquick-clostridium-difficile-gdh
RIDA®QUICK Clostridium diff...
RIDA®QUICK Clostridium difficile GDH is an  immunochromatographic rapid test for the qualitative detection of Clostridium difficile-specific glutam...
pg0845_ridagene-clostridium-difficile-lc2
RIDA®GENE Clostridium diffi...
For in vitro diagnostic use. RIDA®GENE Clostridium difficile is a multiplex real-time PCR for the direct, qualitative detection of Clostridium diff...

Support on hospital acquired infections

Questions? Tap into our team’s expertise. We’re here to support you and your business throughout the testing process to ensure your success

Start typing and press Enter to search